Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A drug-free, engineered hybrid exosome platform alleviates atherosclerosis via inflammation modulation and phenotype remodeling.

Colloids and surfaces. B, Biointerfaces - 1 Oct 2026

Yang Xi, Lei Fenting, He Xinghui, Wu Mengxi, Liu Yilin, Li Qi, Tan Xiao, Ding Keyi, Zhao Ting, Liu Ziyi, Yu Xin, Yu Hong, Li Chunhong

Abstract excerpt

Elevated concentrations of reactive oxygen species (ROS) within the atherosclerotic microenvironment initiate positive feedback loops involving inflammatory mediators, consequently triggering an inflammatory storm between endothelial cells and macrophages. Currently, the treatment of atherosclerosis (AS) mainly focuses on removing lipids, without effective anti-inflammatory and antioxidant therapies. AgNPs with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Atherosclerosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exosomes

Share to Liposomes

Share to Macrophages

Share to Metal Nanoparticles

Share to Reactive Oxygen Species

Share to Silver

Source

Identifiers

PMID: 42167057
DOI: 10.1016/j.colsurfb.2026.115833

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A drug-free, engineered hybrid exosome platform alleviates atherosclerosis via inflammation modulation and phenotype remodeling.PMID 42167057Read ↗

A dual-targeting bio-liposomes nanodrug repair endothelial cell dysfunction and restore macrophage cholesterol flow homeostasis to treat early atherosclerosisSemantic proximity Read ↗

The Dual Role of Extracellular Vesicles in Atherosclerosis: From Pathogenic Mediators to Translational Tools in Diagnosis and Targeted TherapySemantic proximity Read ↗

Biomimetic Nanoparticles Simultaneously Targeting Modulation of Lipid Metabolism and Phenotype of Macrophages for Programmed Atherosclerosis Management.Semantic proximity Read ↗

Targeting Epsins by nanotherapy regulates lipid metabolism and promotes ABCG1-mediated cholesterol efflux to fortify atheroma regressionSemantic proximity Read ↗

A PEG-PLGA-based polymeric capsule as theranostic nanoplatform for active targeting atherosclerosisSemantic proximity Read ↗

Nrf2 activator-encapsulating polymeric nanoparticles and LDL-like nanoparticles target atherosclerotic plaqueSemantic proximity Read ↗

Immunomodulatory mechanisms of submicron phosphatidylserine-exposing polymeric particles (PSPs)Semantic proximity Read ↗

M2 Macrophage-Derived Exosomes Inhibit Atherosclerosis Progression by Regulating the Proliferation, Migration, and Phenotypic Transformation of Smooth Muscle Cells.Semantic proximity Read ↗

An Autologous Macrophage-Based Phenotypic Transformation-Collagen Degradation System Treating Advanced Liver Fibrosis.Semantic proximity Read ↗

Precise theranostic nanomedicines for inhibiting vulnerable atherosclerotic plaque progression through regulation of vascular smooth muscle cell phenotype switching.Semantic proximity Read ↗

Metabolic-switch macrophage cyborgs reverse atherosclerosis by photoacoustic-directed on-demand phenotype delivery.Semantic proximity Read ↗

Targeting VSMCs to suppress macrophage-like phenotype switching that restrains atherogenesis by immunosuppressive oligodeoxynucleotide (A151) functionalized selenium nanoparticles.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.